LLY vs AMGN Comparison
Compare financials and metrics between Eli Lilly and Company (LLY) and Amgen Inc. (AMGN)
Stock Comparison
Metric | LLY | AMGN |
---|---|---|
Market Cap | $838.5 B | $151.0 B |
Gross Margin | 82% | 66% |
Profit Margin | 33% | 7% |
EBITDA margin | 45% | 25% |
Quarterly Revenue | $13.5 B | $9.1 B |
Quarterly Earnings | $4.4 B | $627.0 B |
Quarterly Free Cash Flow | $0 B | $4.4 M |
Trailing 4 Quarters Revenue | $45.0 B | $33.4 B |
Trailing 4 Quarters Earnings | $10.6 B | $4.1 B |
Quarterly Earnings Growth | 101% | -18% |
Annual Earnings Growth | 425% | -31% |
Quarterly Revenue Growth | 45% | 11% |
Annual Revenue Growth | 19% | 15% |
Cash On Hand | $0 | $12.0 B |
Short Term Debt | $0 | $3.6 B |
Long Term Debt | $0 | $56.5 B |
PE | 79.18 | 36.92 |
PS | 18.62 | 4.52 |
PB | 58.55 | 25.69 |
PC | -1.00 | 12.61 |
Liabilities to Equity | -1.00 | 14.63 |
ROA | -100% | 4% |
ROE | 74% | 70% |
Current Ratio | 0.00 | 1.07 |
Quick Ratio | -0.25 | 0.14 |
Long Term Debt to Equity | 0.00 | 9.62 |
Debt to Equity | 0.00 | 10.23 |
Burn Rate | 0.00 | 4.75 |
Cash to Cap | 0.00 | 0.08 |
CCR | 0.00 | 7.02 |
EV to EBITDA | 136.37 | 86.16 |
EV to Revenue | 18.62 | 5.97 |